We provide robot-assisted surgical treatment that ensures curability while preserving function, with a low complication rate. The anal preservation rate exceeds 90%, and we are also capable of performing ISR, the ultimate anal-preserving surgery.

We have multiple types of surgical robots (da Vinci Xi, hinotori, and Hugo [available through participation in clinical research]) and provide high-quality robot-assisted surgery by selecting the most suitable system for each patient. The operating surgeon has experience with more than 5,000 surgical cases.

Providing Medical Institution

Kansai Medical University Hospital

〒573-1191
2-3-1 Shinmachi, Hirakata City

Google Map https://hp.kmu.ac.jp/

Specialty

Minimally invasive surgery: robot-assisted surgery (Nephrology and Urology, Gastrointestinal surgery, orthopedics), TAVI (transcatheter aortic valve implantation), MICS (minimally invasive cardiac surgery: endoscopic mitral valve replacement)
Cancer treatment: surgery, chemotherapy, Molecular targeted drug therapy (immune checkpoint inhibitors), radiation therapy, IMRT (Intensity Modulated Radiation Therapy), tissue-enhanced irradiation, cancer genomic medicine, photoimmunotherapy (unresectable locally advanced or . Locally recurrent head and neck cancer)
Treatment of intractable diseases: Crohn's disease, ulcerative colitis, and various other intractable diseases.
Treatment of orthopedic diseases: various spine surgeries, hip surgeries, knee surgeries

Eligibility Criteria/Exclusions for Treatment

Required clinical information: Age, sex, past medical history, comorbidities, history of abdominal surgery (if any, with details), current medications, and details of colorectal cancer (endoscopic images, CT images, histopathological findings). Treatment period: Approximately 2 weeks of hospitalization for rectal cancer, and about 10 days of hospitalization for colon cancer.

Precautions / Contraindications

The final indication for surgery will be determined after the medical consultation.